Genmab A/S (GNMSF) Divestments (2018 - 2026)
Genmab A's (GNMSF) quarterly Divestments came in at -$579.0 million in Q1 2021, down 6533.33% YoY from $9.0 million in Q1 2020, and down 22572999.42% on a QoQ basis from -$2565.0 in Q3 2020.
Genmab A/S (GNMSF) Divestments (2018 - 2026) Analysis & Trends
Genmab A (GNMSF) has 4 years of Divestments data on file, last reported at -$579.0 million in Q1 2021.
- Quarterly Divestments fell 6533.33% year-over-year to -$579.0 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was -$570.0 million (down 26.21% YoY) and the FY2019 annual result came in at -$1983.0, up 100.0% from the prior year.
- Divestments fell to -$579.0 million in Q1 2021, from -$2565.0 in the prior quarter.
- In the past five years, Divestments ranged from a high of $9.0 million in Q1 2020 to a low of -$579.0 million in Q1 2021.
- A 4-year average of -$171.8 million and a median of -$23.1 million in 2019 frame the typical range for Divestments.
- Annual changes were most pronounced in 2019 — Divestments soared 100.0% — and 2021, when it plunged 6533.33%.
- Tracing GNMSF's Divestments over 4 years: stood at -$414.4 million in 2018, then soared by 100.0% to -$46.0 in 2019, then sank by 5476.09% to -$2565.0 in 2020, then tumbled by 22572999.42% to -$579.0 million in 2021.
- The last three Divestments figures came in at -$579.0 million (Q1 2021), -$2565.0 (Q3 2020), and $9.0 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Jun 30, 2025 | -3.00 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | -8.00 Mn |
| Sep 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | -5.00 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Dec 31, 2023 | -4.00 Mn |
| Mar 31, 2021 | -579.00 Mn |
| Sep 30, 2020 | -2,565.00 |
| Mar 31, 2020 | 9.00 Mn |
| Dec 31, 2019 | -46.00 |
| Sep 30, 2019 | -46.24 Mn |
| Dec 31, 2018 | -414.40 Mn |